Future studies are advocated to fully characterize CD68+ macrophages, to differentiate M1‐polarized and M2‐polarized macrophages, and to investigate adenoma cytokines in patients naïve to SRL or pretreated with SRLs at the surgery. Here, CD68 is linked to adenoma.